Topical Cannabidiol for the Treatment of Chemotherapy-Induced Peripheral Neuropathy

NCT05388058 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Chemotherapy-Induced Peripheral Neuropathy
Malignant Solid Neoplasm

Interventions

DRUG: Cannabidiol
DRUG: Placebo Administration
OTHER: Quality-of-Life Assessment
OTHER: Questionnaire Administration

Sponsor

Mayo Clinic